"Haemophilia A" - Presenting with oral squamous cell carcinoma diagnosis and management strategies

Oral Oncol. 2022 Sep:132:105994. doi: 10.1016/j.oraloncology.2022.105994. Epub 2022 Jul 1.

Abstract

Hemophilia is a hereditary disorder of coagulation that results in deficiency of factor VIII (Hemophilia A) or Factor IX (Hemophilia B) with characteristic X linked mode of inheritance, almost exclusively seen in males while females are asymptomatic carriers.The common clinical manifestation in both is prolonged bleeding on trivial trauma, mainly into larger joints or muscles. Life threatening bleeding episodes can result spontaneously or from trauma to the head or internal organs. Replacement of deficient clotting protein, known as Anti Hemophilic Factor (AHF) is the main stay in the treatment of haemophilia. Any Surgical treatment of these patients is to be planned in Institution hospital where comprehensive care is available. The availability of AHF has enabled surgeons to take up surgeries in patients with haemophilia. We discuss PWH with congenital factor VIII deficiency presented with oral squamous cell carcinoma of left side lower jaw with main aim is to provide insight into surgical management and care protocol of these patients.

Keywords: American Joint Committee on Cancer (AJCC); Anti haemophilic factor (AHF); Oral squamous cell carcinoma; People with Haemophilia (PWH); Retromolar trigone (RMT).

Publication types

  • Letter

MeSH terms

  • Carcinoma, Squamous Cell* / diagnosis
  • Carcinoma, Squamous Cell* / therapy
  • Female
  • Head and Neck Neoplasms*
  • Hemophilia A* / complications
  • Hemophilia A* / diagnosis
  • Hemophilia A* / therapy
  • Humans
  • Male
  • Mouth Neoplasms* / diagnosis
  • Mouth Neoplasms* / therapy
  • Squamous Cell Carcinoma of Head and Neck